News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
260 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Business
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2021 Financial Results
Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2021 on Wednesday, Feb. 23 at 9 a.m., ET.
February 15, 2022
·
1 min read
Resolutions passed at the Extraordinary General Meeting - Feb 15, 2022
Orphazyme A/S, a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, held an Extraordinary General Meeting, at which the general meeting:
February 15, 2022
·
6 min read
Business
Pharnext Appoints Valérie Worrall as Chief Financial Officer
Pharnext SA announces the appointment of Valérie Worrall as Chief Financial Officer, effective March 1st, 2022.
February 15, 2022
·
5 min read
Antidiuretic Drugs Market Size, Developments Status, Trends and Key Players Analysis, Forecast 2028
The report also highlights about changes in the market dynamics due to outbreak of the COVID-19 pandemic.
February 15, 2022
·
7 min read
Dry Eye Drugs Market Share, Comprehensive Analysis, Opportunity Assessment, Future Estimations and Key Industry Segments Poised for Strong Growth in Future 2028
The industry analysis report is considered a valuable source of information about the global Dry Eye Drugs industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.
February 15, 2022
·
7 min read
Self-Sampling Blood Collection and Storage Devices Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028
The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.
February 15, 2022
·
7 min read
Business
RxDefine Expands Its Legal Compliance Leadership Team with Top Recruits from AbbVie and McKinsey Company
RxDefine, the provider of the first digital end-to-end solution for life science commercialization, today announced the hiring of its first General Counsel, Dan Vorhaus, and Director of Compliance, Nicholas Lawrence.
February 15, 2022
·
2 min read
Business
Awakn Life Sciences’ Professor Celia Morgan Named One of the Most Influential Women in the Psychedelics Industry
Professor Morgan, Awakn’s Head of Ketamine-Assisted Therapy for Addiction, Named One Of The 16 Most Influential Women Shaping The Future Of Psychedelics By Insider.
February 15, 2022
·
2 min read
Oncoinvent to Participate in Upcoming Virtual Investor Conferences - Feb 15, 2022
Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced that members of management will participate in two upcoming virtual investor conferences.
February 15, 2022
·
1 min read
Business
Tachyum and Barcelona Supercomputing Center Sign Memorandum of Understanding for Collaboration
Tachyum™ today announced it has entered into a MOU with the Barcelona Supercomputing Center (BSC) in Spain with the intent to collaborate on open supercomputing projects, scientific research, and innovations in AI.
February 15, 2022
·
4 min read
Previous
21 of 26
Next